المؤلفون: Ruiz , Erika, Piamonte, Diego Ernesto, Gómez, Deisy Tatiana, Díaz, Luis Alfonso, Pérez, Luis Alfonso

المصدر: Biomedica; Vol. 44 No. 1 (2024); 35-44 ; Biomédica; Vol. 44 Núm. 1 (2024); 35-44 ; 2590-7379 ; 0120-4157

مصطلحات موضوعية: bone diseases, metabolic, infant, premature, alkaline phosphatase, phosphorus, vitamin D, enfermedades óseas metabólicas, recién nacido prematuro, fosfatasa alcalina, fósforo, vitamina D

وصف الملف: application/pdf

Relation: https://revistabiomedica.org/index.php/biomedica/article/view/6926/5411; Moreira A, Jacob R, Lavender L, Escaname E. Metabolic bone disease of prematurity. Neoreviews. 2015;16:e631-41. https://doi.org/10.1542/neo.16-11-e631; Chinoy A, Mughal MZ, Padidela R. Metabolic bone disease of prematurity: Causes, recognition, prevention, treatment and long-term consequences. Arch Dis Child Fetal Neonatal Ed. 2019;104:F560-6. https://doi.org/10.1136/archdischild-2018-316330; Schulz EV, Wagner CL. History, epidemiology and prevalence of neonatal bone mineral metabolic disorders. Semin Fetal Neonatal Med. 2020;25:101069. https://doi.org/10.1016/j.siny.2019.101069; Abrams SA, Bhatia JJS, Abrams SA, Corkins MR, de Ferranti SD, Golden NH, et al. Calcium and vitamin D requirements of enterally fed preterm infants. Pediatrics. 2013;131:e1676-83. https://doi.org/10.1542/peds.2013-0420; Chacham S, Pasi R, Chegondi M, Ahmad N, Mohanty SB. Metabolic bone disease in premature neonates: An unmet challenge. J Clin Res Pediatr Endocrinol. 2020;12:332-9. https://doi.org/10.4274/jcrpe.galenos.2019.2019.0091; Rayannavar A, Calabria AC. Screening for metabolic bone disease of prematurity. Semin Fetal Neonatal Med. 2020;25:101086. https://doi.org/10.1016/j.siny.2020.101086; Krithika MV, Balakrishnan U, Amboiram P, Shaik MSJ, Chandrasekaran A, Ninan B. Early calcium and phosphorus supplementation in VLBW infants to reduce metabolic bone disease of prematurity: A quality improvement initiative. BMJ Open Qual. 2022;11(Suppl.1):e001841. https://doi.org/10.1136/bmjoq-2022-001841; Yan-Mei C, Xin-Zhu L, Rong Z, Xi-Hong L, Xiao-Mei T, Ping-Yang C, et al. Expert consensus on clinical management of metabolic bone disease of prematurity (2021). Zhongguo Dangdai Erke Zazhi. 2021;23:761-72. https://doi.org/10.7499/j.issn.1008-8830.2105152; Fewtrell M, Prentice A, Cole TJ, Lucas A. Effects of growth during infancy and childhood on bone mineralization and turnover in preterm children aged 8-12 years. Acta Paediatr. 2000;89:148-53. https://doi.org/10.1080/080352500750028744; Ávila A, Urisarri A, Fuentes J, Mandiá N, Sucasas A, Couce M. Metabolic bone disease of prematurity: Risk factors and associated short-term outcomes. Nutrients. 2020;12:3786. https://doi.org/10.3390/nu12123786; Wang J, Zhao Q, Chen B, Sun J, Huang J, Meng J, et al. Risk factors for metabolic bone disease of prematurity: A meta-analysis. PLoS One. 2022;17:e0269180. https://doi.org/10.1371/journal.pone.0269180; Montaner R, Fernández C, Calmarza P, Rite S, Oliván M. Risk factors and biochemical markers in metabolic bone disease of premature newborns. Rev Chil Pediatr. 2017;88:487-94. https://doi.org/10.4067/S0370-41062017000400007; Ukarapong S, Venkatarayappa B, Navarrete C, Berkovitz G. Risk factors of metabolic bone disease of prematurity. Early Hum Dev. 2017;112:29-34. https://doi.org/10.1016/j.earlhumdev.2017.06.010; Chen W, Yang C, Chen H, Zhang B. Risk factors analysis and prevention of metabolic bone disease of prematurity. Medicine (Baltimore). 2018;97:e12861. https://doi.org/10.1097/MD.0000000000012861; Orth L, O’Mara K. Impact of early versus late diuretic exposure on metabolic bone disease and growth in premature neonates. J Pediatr Pharmacol Ther. 2018;23:2633. https://doi.org/10.5863/1551-6776-23.1.26; Tan Y, Tsao P, Chou H, Yen T, Chen C. Hypophosphatemia as an early metabolic bone disease marker in extremely low-birth-weight infants after prolonged parenteral nutrition exposure. JPEN J Parenter Enteral Nutr. 2021;45:1268-74. https://doi.org/10.1002/jpen.2010; Eliakim A, Shiff Y, Nemet D, Dolfin T. The effect of neonatal sepsis on bone turnover in verylow birth weight premature infants. J Pediatr Endocrinol Metab. 2003;16:413-8. https://doi.org/10.1515/jpem.2003.16.3.413; https://revistabiomedica.org/index.php/biomedica/article/view/6926

الاتاحة: https://revistabiomedica.org/index.php/biomedica/article/view/6926

Additional Titles: Incidencia de enfermedad metabólica ósea en neonatos con menos de 32 semanas de gestación en el Hospital Universitario de Santander en Colombia

المؤلفون: Ruiz , Erika, Piamonte, Diego Ernesto, Gómez, Deisy Tatiana, Díaz, Luis Alfonso, Pérez, Luis Alfonso

المصدر: Biomedica; Vol. 44 No. 1 (2024); 35-44; Biomédica; Vol. 44 Núm. 1 (2024); 35-44; 2590-7379; 0120-4157

مصطلحات الفهرس: bone diseases, metabolic, infant, premature, alkaline phosphatase, phosphorus, vitamin D, enfermedades óseas metabólicas, recién nacido prematuro, fosfatasa alcalina, fósforo, vitamina D, info:eu-repo/semantics/article, info:eu-repo/semantics/publishedVersion

URL: https://revistabiomedica.org/index.php/biomedica/article/view/6926
https://revistabiomedica.org/index.php/biomedica/article/view/6926/5411
https://revistabiomedica.org/index.php/biomedica/article/view/6926/5411
*ref*/Moreira A, Jacob R, Lavender L, Escaname E. Metabolic bone disease of prematurity. Neoreviews. 2015;16:e631-41. https://doi.org/10.1542/neo.16-11-e631
*ref*/Chinoy A, Mughal MZ, Padidela R. Metabolic bone disease of prematurity: Causes, recognition, prevention, treatment and long-term consequences. Arch Dis Child Fetal Neonatal Ed. 2019;104:F560-6. https://doi.org/10.1136/archdischild-2018-316330
*ref*/Schulz EV, Wagner CL. History, epidemiology and prevalence of neonatal bone mineral metabolic disorders. Semin Fetal Neonatal Med. 2020;25:101069. https://doi.org/10.1016/j.siny.2019.101069
*ref*/Abrams SA, Bhatia JJS, Abrams SA, Corkins MR, de Ferranti SD, Golden NH, et al. Calcium and vitamin D requirements of enterally fed preterm infants. Pediatrics. 2013;131:e1676-83. https://doi.org/10.1542/peds.2013-0420
*ref*/Chacham S, Pasi R, Chegondi M, Ahmad N, Mohanty SB. Metabolic bone disease in premature neonates: An unmet challenge. J Clin Res Pediatr Endocrinol. 2020;12:332-9. https://doi.org/10.4274/jcrpe.galenos.2019.2019.0091
*ref*/Rayannavar A, Calabria AC. Screening for metabolic bone disease of prematurity. Semin Fetal Neonatal Med. 2020;25:101086. https://doi.org/10.1016/j.siny.2020.101086
*ref*/Krithika MV, Balakrishnan U, Amboiram P, Shaik MSJ, Chandrasekaran A, Ninan B. Early calcium and phosphorus supplementation in VLBW infants to reduce metabolic bone disease of prematurity: A quality improvement initiative. BMJ Open Qual. 2022;11(Suppl.1):e001841. https://doi.org/10.1136/bmjoq-2022-001841
*ref*/Yan-Mei C, Xin-Zhu L, Rong Z, Xi-Hong L, Xiao-Mei T, Ping-Yang C, et al. Expert consensus on clinical management of metabolic bone disease of prematurity (2021). Zhongguo Dangdai Erke Zazhi. 2021;23:761-72. https://doi.org/10.7499/j.issn.1008-8830.2105152
*ref*/Fewtrell M, Prentice A, Cole TJ, Lucas A. Effects of growth during infancy and childhood on bone mineralization and turnover in preterm children aged 8-12 years. Acta Paediatr. 2000;89:148-53. https://doi.org/10.1080/080352500750028744
*ref*/Ávila A, Urisarri A, Fuentes J, Mandiá N, Sucasas A, Couce M. Metabolic bone disease of prematurity: Risk factors and associated short-term outcomes. Nutrients. 2020;12:3786. https://doi.org/10.3390/nu12123786
*ref*/Wang J, Zhao Q, Chen B, Sun J, Huang J, Meng J, et al. Risk factors for metabolic bone disease of prematurity: A meta-analysis. PLoS One. 2022;17:e0269180. https://doi.org/10.1371/journal.pone.0269180
*ref*/Montaner R, Fernández C, Calmarza P, Rite S, Oliván M. Risk factors and biochemical markers in metabolic bone disease of premature newborns. Rev Chil Pediatr. 2017;88:487-94. https://doi.org/10.4067/S0370-41062017000400007
*ref*/Ukarapong S, Venkatarayappa B, Navarrete C, Berkovitz G. Risk factors of metabolic bone disease of prematurity. Early Hum Dev. 2017;112:29-34. https://doi.org/10.1016/j.earlhumdev.2017.06.010
*ref*/Chen W, Yang C, Chen H, Zhang B. Risk factors analysis and prevention of metabolic bone disease of prematurity. Medicine (Baltimore). 2018;97:e12861. https://doi.org/10.1097/MD.0000000000012861
*ref*/Orth L, O’Mara K. Impact of early versus late diuretic exposure on metabolic bone disease and growth in premature neonates. J Pediatr Pharmacol Ther. 2018;23:2633. https://doi.org/10.5863/1551-6776-23.1.26
*ref*/Tan Y, Tsao P, Chou H, Yen T, Chen C. Hypophosphatemia as an early metabolic bone disease marker in extremely low-birth-weight infants after prolonged parenteral nutrition exposure. JPEN J Parenter Enteral Nutr. 2021;45:1268-74. https://doi.org/10.1002/jpen.2010
*ref*/Eliakim A, Shiff Y, Nemet D, Dolfin T. The effect of neonatal sepsis on bone turnover in verylow birth weight premature infants. J Pediatr Endocrinol Metab. 2003;16:413-8. https://doi.org/10.1515/jpem.2003.16.3.413